United States Cellular Preferred 5.500% due 2070 (UZE)
REAL ESTATE • Insurance - Life • NYSE
Market Cap: $2.74B
Last updated: Nov 17, 2026 at 4:10 PM ET
United States Cellular Preferred 5.500% due 2070 (UZE) Stock Chart
United States Cellular Preferred 5.500% due 2070 (UZE) has a latest price of $14.77 on Nov 17, 2026, 18.7% below its 52-week high of $18.16. Its price fell 13.4% over the past 12 months. The month-end price fell 43.2% over the 5 years through Oct 2026, a compound annual decline of 10.7%.
Price Chart
From Dec 2020 to Oct 2026, its highest month-end close was $26.61 in Oct 2021 and its lowest $14.30 in May 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart UZE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for UZE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 10.1%, and over 6 months it fell 13.5%. The month-end price rose 1.7% over the 3 years through Oct 2026, a compound annual rate of 0.6%.
| Period | Change |
|---|---|
| 1 month | -5.4% |
| 3 months | -10.1% |
| 6 months | -13.5% |
| 12 months | -13.4% |
| 12 months, with dividends | -5.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +1.7% | +0.6% |
| 5 years | -43.2% | -10.7% |
Price by Year
Its best calendar year was 2024, when the price rose 25.4%, and its weakest was 2022, when it fell 45.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $15.12 | -15.1% |
| 2025 | $17.81 | -20.4% |
| 2024 | $22.38 | +25.4% |
| 2023 | $17.85 | +22.9% |
| 2022 | $14.52 | -45.0% |
| 2021 | $26.40 | +4.7% |
Trading Range
The price is 5.9% below its 50-day average of $15.69 and 12.0% below its 200-day average of $16.79.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $14.77 | |
| 52-week high | $18.16 | -18.7% |
| 52-week low | $14.77 | 0.0% |
| 50-day average | $15.69 | -5.9% |
| 200-day average | $16.79 | -12.0% |
Price Risk
Over 3 years, its largest fall from a peak was 28.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.24 |
| Largest fall, 1 year | -20.1% |
| Largest fall, 3 years | -28.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About UZE
What is UZE's 1-year price change?
United States Cellular Preferred 5.500% due 2070's price fell 13.4% over the past 12 months. With dividends included, the 12-month total return was -5.3%.
What is UZE's 5-year price change?
United States Cellular Preferred 5.500% due 2070's month-end price fell 43.2% over the 5 years through Oct 2026, a compound annual decline of 10.7%. These figures leave out dividends.
What is UZE's 52-week high and low?
United States Cellular Preferred 5.500% due 2070's 52-week high is $18.16 and its 52-week low is $14.77. Its latest price of $14.77 on Nov 17, 2026 is 18.7% below the high.
What is UZE's beta?
United States Cellular Preferred 5.500% due 2070's 1-year beta against the S&P 500 is 0.24, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 20.1%.
Is the UZE chart free?
Yes. Advanced Charting for UZE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
UZE pages: Overview, Dividends, Charting, Financials